| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 13,334 | 10,961 | 5,155 | 8,985 | | Cost of Revenue | 6,939 | 5,390 | 3,042 | 4,856 | | | Gross Profit | 6,395 | 5,571 | 2,113 | 4,129 | | | Operating Expenses | | Research Development | 1,518 | 1,489 | 769 | 844 | | Selling General and Administrative | 7,631 | 5,938 | 4,731 | 5,967 | | Non Recurring |
-
|
-
| (249) | (1,455) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,586) | (1,856) | (3,138) | (1,227) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 555 | (212) | 279 | (2,137) | | Earnings Before Interest And Taxes | (1,883) | (2,349) | (3,148) | (3,364) | | Interest Expense |
-
|
-
|
-
| (293) | | Income Before Tax | (1,883) | (2,349) | (3,148) | (3,071) | | Income Tax Expense | 433 | (1,739) | (1) | 601 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,316) | (610) | (3,147) | (3,672) | | | Non-recurring Events | | Discontinued Operations | 79 | 122 | 104 | (450) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,237) | (488) | (3,043) | (4,122) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,237) | ($488) | ($3,043) | ($4,122) |
|
0.51% Nasdaq 0.00%
Income Statement
